Celera Genomics of Rockville, Md., said it had entered an agreement to provide a multi-year subscription to five of its databases to the Australian National Health and Medical Research Council.
Terms of the deal were not disclosed but other subscribers have reportedly paid between $25 million and $50 million for three- to five-year subscriptions.
Separately, after announcing the sequencing of the human genome, Celera said it was going to focus its attention on proteomics and other discovery efforts that are subject to intellectual property protection.